XyCAD-CXR

XyCAD-CXR assists radiologists with management of critical cases through provision of a triaged worklist, allowing caregivers to help patients who need it most.

Its AI algorithms detect, localize, and classify numerous diseases as associated with chest X-rays.  These disease types include cardiomegaly, mass, nodules, pneumonia thorax, consolidation, etc.

How it works ...

Productivity​ Gains

With less than 3 minutes spent per chest X-ray, XyCAD-CXR’s triage capability assists Radiologists in reviewing critical cases first.

Detect, Localize & Predict

Xylexa’s AI algorithms detect, localize, and classify numerous diseases as associated with chest X-rays, including cardiomegaly, mass, nodules, pneumonia thorax, consolidation, etc.

Disease Severity & Progression

XyCAD-CXR assists Radiologists asses severity and progression of various diseases via visual cues such as heatmaps.

Clinical Benefits

Decision making with confidence

Xylexa empowers Radiologists to deliver improved clinical insights for their patients via use of XyCAD-CXR.

Xylexa empowers Radiologists to deliver improved clinical insights for their patients via use of XyCAD-CXR.

Multi-model SaMD

Examines chest X-rays for multiple disease types, such as mass, nodules, pneumothorax, pleural effusion, etc.

Decision-making

XyCAD-CXR delivers double reading quality with a single human reader.

Operational Efficiency

Examines chest X-rays, identifies concerns, and offers the Radiologists a priority list for quick action.

Workflow Efficiency

Ubiquitous access PACS, DICOM, and AI analytics anywhere, on any device, at all times.

Image Interpretation Efficiency

Image interpretation, decision making, and reporting time reduced by up to 25%.

Diagnostic Efficiency

XyCAD-CXR improved Radiologists' chest X-ray interpretation accuracy by up to 20% in clinical settings.

Clinically Validated

Improved Diagnostic Accuracy

In clinical and lab trials, XyCAD-CXR has demonstrated remarkable ability for Radiologists to deliver improved clinical diagnosis for their patients.

Sensitivity
0 %
Specificity
0 %
auc - roc
0 %